Is elevated cortisol with adrenocorticotropic hormone (ACTH) levels greater than 15 and a failed low-dose dexamethasone suppression test (LDDST) with a greater than 50% drop sufficient to diagnose adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing ACTH-Dependent Cushing's Syndrome

Elevated cortisol with ACTH levels >15 pg/mL and a failed low-dose dexamethasone suppression test (LDDST) with >50% drop is sufficient to diagnose ACTH-dependent Cushing's syndrome. 1, 2

Diagnostic Criteria for ACTH-Dependency

  • ACTH levels >5 pg/mL are detectable and suggest ACTH-dependent Cushing's syndrome with high certainty 1
  • ACTH levels >29 pg/mL have 70% sensitivity and 100% specificity for diagnosing Cushing's disease (pituitary source of ACTH) 1, 2
  • Morning plasma ACTH levels combined with elevated cortisol and failed LDDST establish the diagnosis of ACTH-dependent Cushing's syndrome 2

Diagnostic Algorithm

  1. First step: Confirm hypercortisolism using at least two first-line tests:

    • 24-hour urinary free cortisol (UFC)
    • Late-night salivary cortisol (LNSC)
    • Low-dose dexamethasone suppression test (LDDST) 2
  2. Second step: Determine ACTH-dependency:

    • ACTH levels >5 pg/mL indicate ACTH-dependent Cushing's syndrome 1, 2
    • ACTH levels <5 pg/mL suggest ACTH-independent (adrenal) Cushing's syndrome 1
  3. Third step: For confirmed ACTH-dependent Cushing's syndrome, determine the source:

    • Pituitary MRI to identify adenoma (sensitivity 63%, specificity 92%) 2
    • CRH stimulation test (≥20% increase in cortisol supports pituitary origin) 2
    • Bilateral inferior petrosal sinus sampling (BIPSS) if needed 1, 2

Important Clinical Considerations

  • ACTH-dependent Cushing's syndrome accounts for 75-80% of pediatric cases and is most commonly caused by pituitary adenomas 3
  • In adults with Cushing's syndrome, ACTH-dependent forms are also predominant 1
  • The combination of elevated cortisol, ACTH >15 pg/mL, and failed LDDST with >50% drop strongly supports ACTH-dependent Cushing's syndrome 1, 2

Common Pitfalls and Caveats

  • Cyclic Cushing's syndrome can produce inconsistent results, requiring periodic re-evaluation 1
  • Pseudo-Cushing's states (severe obesity, alcoholism, depression) can cause false positive results in screening tests and must be excluded 1
  • Exogenous glucocorticoid use must be ruled out before biochemical testing 2
  • In pediatric patients, growth failure combined with weight gain has high sensitivity and specificity for Cushing's syndrome 3

Further Diagnostic Steps

  • For confirmed ACTH-dependent Cushing's syndrome, pituitary MRI is recommended as the next step 1, 2
  • If pituitary imaging is negative or equivocal, BIPSS should be performed to differentiate between pituitary and ectopic sources of ACTH 2, 4
  • BIPSS has diagnostic criteria of central-to-peripheral ACTH ratio ≥2:1 before CRH stimulation and ≥3:1 after stimulation, with sensitivity of 100% 2

The diagnostic approach should be systematic, and while the combination of elevated cortisol, ACTH >15 pg/mL, and failed LDDST with >50% drop is highly suggestive of ACTH-dependent Cushing's syndrome, additional testing is typically required to confirm the source of ACTH excess for definitive treatment planning 1, 2, 4.

References

Guideline

Cushing's Syndrome Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for ACTH-Dependent Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Approach to the patient with possible Cushing's syndrome.

The Journal of clinical endocrinology and metabolism, 2009

Related Questions

What is the most likely cause of ambulatory dysfunction in a patient with worsening weakness, unintentional weight gain, and purple abdominal striae, taking prednisone (corticosteroid) 20mg daily?
What is the diagnostic approach to hypercortisolism?
What is the most likely type of Cushing's syndrome in a patient with elevated Adrenocorticotropic hormone (ACTH) and cortisol levels?
What does a cortisol level of 1.2 after a dexamethasone (DEX) suppression test indicate?
What is the next step in management for a 30-year-old woman with suspected Cushing's syndrome (CS), presenting with muscle weakness, weight gain, facial plethora, supraclavicular fat pads, truncal obesity, and purple striae, as well as hypertension (high blood pressure)?
What percentage of patients become infertile after receiving 3.7 Gigabecquerels (GBq) of radioactive Iodine-131 (I-131)?
Is a failed Low-Dose Dexamethasone Suppression Test (LDDST) with two random elevated cortisol levels and normal Adrenocorticotropic Hormone (ACTH) levels sufficient to establish Adrenocorticotropic Hormone (ACTH) dependence?
What is the percentage likelihood of developing a secondary cancer after receiving 3.7 Gigabecquerels (GBq) of radioactive Iodine-131 (I-131)?
Is two serum elevated cortisol levels with Adrenocorticotropic hormone (ACTH) >15 pg/mL and a failed Low-Dose Dexamethasone Suppression Test (LDDST) with a greater than 50% drop sufficient to proceed to Bilateral Inferior Petrosal Sinus Sampling (BIPSS) if Magnetic Resonance Imaging (MRI) is inconclusive?
What are the initial ventilator settings for a Chronic Obstructive Pulmonary Disease (COPD) patient in Type 2 respiratory failure?
What's the next step in diagnosis for a patient with Cushing's disease suspected after a Low-Dose Dexamethasone Suppression Test (LDDST) showing more than 50% suppression of cortisol to a level of 6 ug/dL and an inconclusive MRI?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.